Cardiovascular Primary Prevention

Also known as: Cardiovascular Primary Prevention Strategy / Primary Cardiovascular Prevention / Primary Prevention of Cardiovascular Diseases / Primary Prevention of Cardiovascular Disease / Primary prevention of cardiovascular disease (regime/therapy)

Drug	Drug Name	Drug Description
DB01098	Rosuvastatin	An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.

Drug	Drug Name	Target	Type
DB01098	Rosuvastatin	3-hydroxy-3-methylglutaryl-coenzyme A reductase	target
DB01098	Rosuvastatin	Cytochrome P450 2C9	enzyme
DB01098	Rosuvastatin	Multidrug resistance-associated protein 4	transporter
DB01098	Rosuvastatin	Solute carrier organic anion transporter family member 1A2	transporter
DB01098	Rosuvastatin	Solute carrier organic anion transporter family member 1B3	transporter
DB01098	Rosuvastatin	Solute carrier organic anion transporter family member 2B1	transporter
DB01098	Rosuvastatin	Cystine/glutamate transporter	transporter
DB01098	Rosuvastatin	Solute carrier organic anion transporter family member 1B1	transporter
DB01098	Rosuvastatin	Bile salt export pump	transporter
DB01098	Rosuvastatin	ATP-binding cassette sub-family G member 2	transporter
DB01098	Rosuvastatin	Serum albumin	carrier
DB01098	Rosuvastatin	Canalicular multispecific organic anion transporter 1	transporter
DB01098	Rosuvastatin	Solute carrier family 22 member 8	transporter
DB01098	Rosuvastatin	Sodium/bile acid cotransporter	transporter
DB01098	Rosuvastatin	Integrin alpha-L	target

Drug	Drug Name	Phase	Status	Count
DB01373	Calcium	Not Available	Recruiting	1